Physicochemical Properties
| Molecular Formula | C24H36O2 |
| Molecular Weight | 356.54 |
| Exact Mass | 355.264 |
| CAS # | 81926-94-5 |
| Related CAS # | Docosahexaenoic acid ethyl ester-d5;2692624-15-8;Docosahexaenoic acid ethyl ester-d5-1;159146-01-7 |
| PubChem CID | 9831416 |
| Appearance | Typically exists as solid at room temperature |
| LogP | 5.994 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 16 |
| Heavy Atom Count | 26 |
| Complexity | 490 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | C(/CCC(=O)OCC)=C/C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC |
| InChi Key | ITNKVODZACVXDS-YNUSHXQLSA-N |
| InChi Code | InChI=1S/C24H36O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26-4-2/h5-6,8-9,11-12,14-15,17-18,20-21H,3-4,7,10,13,16,19,22-23H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17-,21-20- |
| Chemical Name | ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vivo | Twice daily for seven days, 500 mg/kg of docosahexaenoic acid ethyl ester (DHA-EE) intraperitoneally (i.p.) amplifies the 6-OHDA-induced decrease in striatal dopamine levels [2]. |
| References |
[1]. Dahms I, et al. Safety of docosahexaenoic acid (DHA) administered as DHA ethyl ester in a 9-month toxicity study in dogs. Food Chem Toxicol. 2016;92:50-57. [2]. Kabuto H, et al. Docosahexaenoic acid ethyl ester enhances 6-hydroxydopamine-induced neuronal damage by induction of lipid peroxidation in mouse striatum. Neurochem Res. 2009;34(7):1299-1303. |
| Additional Infomation | Ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate is a long-chain fatty acid ethyl ester resulting from the formal condensation of the carboxy group of (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoic acid with the hydroxy group of ethanol. It is functionally related to an all-cis-docosa-4,7,10,13,16,19-hexaenoic acid. |
Solubility Data
| Solubility (In Vitro) | DMSO: 100 mg/mL (280.47 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 2.5 mg/mL (7.01 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: 2.5 mg/mL (7.01 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (7.01 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.8047 mL | 14.0237 mL | 28.0473 mL | |
| 5 mM | 0.5609 mL | 2.8047 mL | 5.6095 mL | |
| 10 mM | 0.2805 mL | 1.4024 mL | 2.8047 mL |